
Jared Brosch
Associate Professor of Clinical Neurology · Indiana University School of Medicine
Credentials: · · ·
History
Research
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Nature Medicine · 2021 · 305 citations
Brain · 2019 · 151 citations
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
Alzheimer s & Dementia · 2019 · 129 citations

21 papers

20 papers

19 papers

10 papers

9 papers

9 papers

7 papers

7 papers
Grants
- 2021–2031
Indiana Alzheimer's Disease Research Center
National Institute on Aging · P30
Project lead · $2.5M · Indiana University Indianapolis
Clinical trials
- 2024–2026
Nicotinic Acid for the Treatment of Alzheimer's Disease
Principal investigator · Recruiting · Phase 1, Phase 2
Indiana University
- 2026–2028
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Site PI · Recruiting · Phase 2
Eli Lilly and Company
- 2024–2034
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
- 2024–2034
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine


